ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Seattle, WA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Coronavirus Infections
Human Influenza
Communicable Diseases
Post-Acute COVID-19 Syndrome
Pneumonia
Syndrome

COVID-19 trials near Seattle, WA, USA:

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Seattle, Washington, United States and 66 other locations

The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together.This study is seeking healthy...

Enrolling
COVID-19 (Coronavirus Disease 2019)
Influenza
Biological: Investigational COVID-19 Vaccine
Combination Product: Investigational Influenza and COVID-19 Combination Vaccine

Phase 1, Phase 2

BioNTech
BioNTech

Seattle, Washington, United States and 30 other locations

The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...

Enrolling
COVID-19 SARS-CoV-2 Infection
Drug: placebo
Drug: ibuzatrelvir

Phase 3

Pfizer
Pfizer

Redmond, Washington, United States of America and 89 other locations

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...

Enrolling
Coronavirus Disease (COVID-19)
Drug: Placebo
Drug: Molnupiravir

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Redmond, Washington, United States of America and 176 other locations

studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...

Enrolling
COVID-19
SARS-CoV-2 Virus
Biological: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose
Biological: Variant-adapted BNT162b2 (Omicron XBB.1.5) 3 microgram dose

Phase 2, Phase 3

BioNTech
BioNTech

Seattle, Washington, United States and 114 other locations

the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...

Enrolling
Myocarditis
Diagnostic Test: Cardiac Imaging

Phase 4

Pfizer
Pfizer

Seattle, Washington, United States and 31 other locations

the chances of contracting coronavirus disease 2019 (COVID-19) or developing a severe form of COVID-19 disease i...

Enrolling
COVID-19 Infection
Plasma Cell Myeloma
Biological: COVID-19 Vaccine
Biological: Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1

Phase 2

GeoVax

Seattle, Washington, United States and 5 other locations

) neo-antigen in subjects with relapsing multiple sclerosis (RMS).COVID-19 sub-study:The purpose of this research sub-study is to e...

Active, not recruiting
Relapsing Multiple Sclerosis
Biological: 23-valent pneumococcal polysaccharide vaccine (23-PPV)
Biological: Tetanus toxoid (TT) containing vaccine (Td, Tdap)

Phase 3

Novartis
Novartis

Kirkland, Washington, United States and 297 other locations

treatment in Study M16-067 with no final endoscopy due to the Covid-19 pandemic or due to the geopolitical conflict in Ukraine and ...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: placebo for risankizumab
Drug: risankizumab

Phase 3

AbbVie
AbbVie

Seattle, Washington, United States and 431 other locations

in Study M16-006 or Study M15-991 with no final endoscopy due to the Covid-19 pandemic. Additional objectives are to further invest...

Active, not recruiting
Crohn's Disease
Drug: Placebo for Risankizumab IV
Drug: Risankizumab SC

Phase 3

AbbVie
AbbVie

Seattle, Washington, United States and 497 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems